Biomarker Specialist Activiomics appoints Dr Trevor Nicholls as Non-Executive Chairman
Advertisement
Activiomics Limited. has announced the appointment of industry leader Dr Trevor Nicholls to its Board as Non-Executive Chairman.
Dr Nicholls has over 30 years’ experience of building international businesses in the life science industry. Currently he is CEO of CABI, a not-for-profit inter-governmental organisation owned by 46 member countries worldwide and is Non-Executive Chairman of Oxford Nanopore Technologies, which is developing the GridION system, a new generation of electronic molecular analysis system for use in scientific research, personalised medicine, crop science, and security/defence. His previous board roles include Chief Commercial Officer of Affymetrix Inc, based in California and, prior to that, CEO of Oxagen, a UK biotech company where he raised £50m over three venture-backed financing rounds and secured major commercial partnerships and academic collaborations.